GIPR Agonist LY3537021

**Semantic type:** Pharmacologic Substance

**Definition:** A long-acting glucose-dependent insulinotropic polypeptide receptor (GIPR) agonist, with potential weight-reducing, anti-diabetic, anti-nauseant and anti-emetic activities. Upon subcutaneous administration, GIPR agonist LY3537021 targets, binds to and activates GIPR. This may moderate nausea and vomiting, and reduce body weight and blood glucose levels.

**Synonyms:** - Glucose-dependent Insulinotropic Polypeptide Receptor Agonist LY3537021 - LY 3537021 - LY-3537021 - LY3537021